Current Indications for Fractionated and Synthetic Heparins in Oncologic Patients

Webinar, September 4, 2025 16:00 CET

Playlist

Heparins in Oncologic Patients – Introduction

Lars Asmis

Heparins – Basics and Physiology

Lars Asmis

LMWH – Current Indications in Oncologic Patients

Fondaparinux – Current Indications in Oncologic Patients

Heparins in Oncologic Patients – Q&A- Session

Lars Asmis

Wolfgang Korte

Ecaterina Scarlatescu

Speakers:

	Lars Asmis Privatdozent der Universität Zürich, Hematologie und Interne Medizin FMH, Hematologie FAMH, Leiter Zentrum für perioperative Thrombose und Hämostase (ZPTH), Zürich, Switzerland
	Ecaterina Scarlatescu, MD, PhD Associate Professor, Consultant Anesthesiologist, Department of Anesthesia and Intensive Care, Fundeni Clinical Institute, Bucharest, Romania

Panelist:

Wolfgang Korte, MD, PhD Professor of Medicine (University of Berne), former Head Physician and Director of Center for Laboratory Medicine, Haemostasis and Haemophilia Center, St. Gallen, Switzerland